Pharmafile Logo

Glaucoma in perspective

- PMLiVE

GSK and CureVac to advance mRNA COVID-19 and flu vaccine candidates

The vaccines produced promising preliminary results in phase 1 trials

- PMLiVE

BioNTech and UK government partner to accelerate mRNA cancer immunotherapies

The partnership hopes to provide personalised therapies for up to 10,000 patients

- PMLiVE

bluebird bio sells second FDA priority review voucher for $95m

The company sold its first voucher to Dutch biotech Argenx for $102m

Intelligent and powerful Data/Publication Dissemination with Read, by QxMD

You can get more information on QxMD Read here.  Or contact us directly to discuss here.

Medscape Medical Affairs

- PMLiVE

Amgen and Synaffix sign licensing agreement worth up to $2bn

Amgen will gain access to Synaffix' proprietary antibody-drug conjugates technologies

- PMLiVE

Takeda therapy shows promise in rare blood clotting disorder

Phase 3 results show the enzyme replacement therapy reduced thrombocytopenia events by 60%

- PMLiVE

WHO reports new Omicron subvariant cases detected in 29 countries worldwide

The new Omicron subvariant is spreading rapidly in the US

- PMLiVE

Jasper Therapeutics’ briquilimab given orphan drug designation in EU

The drug will be used for transplant patients with SCID, AML and MDS

- PMLiVE

The dissemination and consumption of medical literature is evolving

QxMD, part of the WebMD Health Network discusses how they are going to evolve its publication solution, Read by QxMD in 2023.

Medscape Medical Affairs

- PMLiVE

World Antimicrobial Awareness Week 2022

Reports from the World Health Organization show that AMR is one of the top ten threats to global health, causing 1.3 million deaths in 2019

How to Increase Engagement During Virtual Events

Tip #7 - How do you increase engagement during virtual events? Make it fun! ️ See all Top 10 tips: https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links